Male hypogonadism – brief review of symptoms, types and ways of treatment
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.070Keywords
hypogonadism, testosterone therapy, Klinefelter Syndrome, metabolic syndrome, obesityAbstract
Appropriate concentration of androgens is necessary for general men’s health, especially for development and maintain reproductive and sexual function, as well as metabolic balance. The state of deficiency of testosterone or its inadequate action, as well as inability to produce good quality semen is called hypogonadism. Depending on the function of the testicles, production of androgens and sperm is also conditioned on hypothalamus-pituitary axis, metabolic status and age of the individual. Considering that, hypogonadism of primary, secondary, functional or late-onset origin may be recognised. As it concerns susceptible matter of sexual and reproductive health, it requires special interest of differently clinicians, i.e. endocrinologists, andrologists or urologists.
References
Bhasin S, Brito JP, Cunningham GR, et al (2018) Testosterone Therapy in Men with Hypogonadism: An Endocrine Society. J. Clin. Endocrinol. Metab. 103:1715–1744
Byrne MM, Nieschlag E (2003) Testosterone replacement therapy in male hypogonadism. J. Endocrinol. Invest. 26:481–489
Carrageta DF, Oliveira PF, Alves MG, Monteiro MP (2019) Obesity and male hypogonadism: Tales of a vicious cycle. Obes. Rev. 20:1148–1158
Carrasquillo R, Chu K, Ramasamy R (2018) Novel Therapy for Male Hypogonadism. Curr. Urol. Rep. 19:1–8
Corona G, Rastrelli G, Vignozzi L, Maggi M (2012) Emerging medication for the treatment of male hypogonadism. Expert Opin. Emerg. Drugs 17:239–259
Cumming DC, Quigley ME, Yen SSC (1983) Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab 57:671–673. https://doi.org/10.1210/jcem-57-3-671
Daniell HW (2002) Hypogonadism in men consuming sustained-action oral opioids. J Pain 3:377–384. https://doi.org/10.1054/jpai.2002.126790
El Osta R, Grandpre N, Monnin N, et al (2017) Hypogonadotropic hypogonadism in men with hereditary hemochromatosis. Basic Clin. Androl. 27
Ferlin A, Garolla A, Ghezzi M, et al (2021) Sperm Count and Hypogonadism as Markers of General Male Health. Eur Urol Focus 7:205–213. https://doi.org/10.1016/j.euf.2019.08.001
Kumar P, Kumar N, Thakur DS, Patidar A (2010) Male hypogonadism: Symptoms and treatment. J. Adv. Pharm. Technol. Res. 1:297–301
Naifar M, Rekik N, Messedi M, et al (2015) Male hypogonadism and metabolic syndrome. Andrologia 47:579–586. https://doi.org/10.1111/and.12305
Rigon FA, Ronsoni MF, Hohl A, van de Sande-Lee S (2019) Effects of Bariatric Surgery in Male Obesity-Associated Hypogonadism. Obes Surg 29:2115–2125. https://doi.org/10.1007/s11695-019-03829-0
Saylam B, Efesoy O, Ayan S (2011) The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. Fertil Steril 95:809–811. https://doi.org/10.1016/j.fertnstert.2010.09.021
Shabsigh A, Kang Y, Shabsign R, et al (2005) Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med 2:716–721. https://doi.org/10.1111/j.1743-6109.2005.00075.x
Wu FCW, Tajar A, Beynon JM, et al (2010) Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. N Engl J Med 363:123–135. https://doi.org/10.1056/nejmoa0911101
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 571
Number of citations: 0